Cartesian Therapeutics, Inc. (RNAC)

Nasdaq: RNAC · Pharmaceutical Preparations · Frederick, MD · filing with the SEC since 2009

Grade3.2

◀ Past 3.6● Present 2.5▶ Future 3.5

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Report filed	Mar 9, 2026	Mar 13, 2025	Mar 7, 2024	Mar 2, 2023	Mar 10, 2022	Mar 12, 2021	Mar 12, 2020	Mar 15, 2019	Mar 15, 2018	Mar 28, 2017
Revenue	400	38,275	26,004	110,777	85,077	16,597	6,677	903	207	8,083
Research and development	58,034	45,105	71,260^r	72,377	68,736	54,505	42,743	47,687	45,165	29,702
General and administrative	31,468	30,126	40,450^r	23,862	20,938	18,913	16,389	18,238	18,826	13,051
Total operating expenses	146,202	82,810	112,420	96,239	89,674	73,418	59,132	65,925	63,991	42,753
Operating income	-143,405	-43,897	-86,416	14,538	-4,597	-56,821	-52,455	-65,022	-63,784	-34,670
Interest expense	·	0	2,100	3,000	2,800	1,600	1,500	1,494	1,206	1,253
Interest and investment income	6,579	7,386	4,964	2,073	44	260	834	1,050	617	234
Other income (expense), net	-2,010	606	691	330	15	89	-1,306	10	-152	4
Total non-operating income (expense)	3,910	-33,240	·	·	·	·	·	·	·	·
Income before income taxes	-139,495	-77,137	-238,710	34,770	-9,721	-68,876	-55,350	·	·	·
Income tax expense	-9,193	287	-19,000	-609	15,966	0	0	·	·	·
Net income	-130,302	-77,424	-219,710	35,379	-25,687	-68,876	-55,350	-65,336	-65,321	-36,210
Net income to common shareholders	-130,302	-77,424	-257,260	35,379	-25,687	-68,876	-55,350	-65,336	-65,321	-40,776
Earnings per share, basic	-5.02	-4.48	-49.76^r	7.20^b	-6.60^b	-20.40^b	-36.60^b	·	·	·
Earnings per share, diluted	-5.02	-4.49	-49.76^r	3.00^b	-6.60^b	-20.40^b	-36.60^b	·	·	·
Earnings per share, basic and diluted	·	·	·	·	·	-20.40^b	-36.60^b	-87.60^b	-96.00^b	-116.70^b
Weighted average shares, basic	25,973,329	17,276,822	5,170,319^r	4,825,285^b	3,810,960^b	3,373,406^b	1,518,284^b	·	·	·
Weighted average shares, diluted	25,973,329	17,357,943	5,170,319^r	4,862,496^b	3,810,960^b	3,373,406^b	1,518,284^b	·	·	·
Weighted average shares, basic and diluted	·	·	·	·	·	3,373,406^b	1,518,284^b	746,310^b	680,835^b	349,798^b

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-30 reverse split of Apr 2024.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it sold

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:Revenues

Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense

General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense

Total operating expenses the running costs togetherus-gaap:OperatingExpenses

Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss

Interest expense what its borrowing cost

us-gaap:InterestExpenseDebt
us-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense

Interest and investment income what its cash and investments earned

us-gaap:InvestmentIncomeInterest
us-gaap:InvestmentIncomeNet

Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense

Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense

Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit

Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss

Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic

Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic

Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted

Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted

Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic

Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted

SI Assistanton RNAC · research, not advice